Enrique Hasbún

Directeur/Membre du Conseil chez Algenis SpA

Health Technology

Relations actives

Nom	Sexe	Age	Sociétés liées	Collaboration
Pablo D. T. Valenzuela	M	-	Algenis SpA Algenis SpA BiotechnologyHealth Technology Algenis SpA conducts research on small molecules derived from microalgae. It produces, formulation and clinical developments bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases. The company also conducted academic clinical research and published their work in several peer-reviewed journals. Algenis was founded in 2002 and is headquartered in Santiago, Chile.	-
Jorge Selume Zaror	M	73	Algenis SpA Algenis SpA BiotechnologyHealth Technology Algenis SpA conducts research on small molecules derived from microalgae. It produces, formulation and clinical developments bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases. The company also conducted academic clinical research and published their work in several peer-reviewed journals. Algenis was founded in 2002 and is headquartered in Santiago, Chile.	-
Alexander Seelenberger Farba	M	45	Algenis SpA Algenis SpA BiotechnologyHealth Technology Algenis SpA conducts research on small molecules derived from microalgae. It produces, formulation and clinical developments bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases. The company also conducted academic clinical research and published their work in several peer-reviewed journals. Algenis was founded in 2002 and is headquartered in Santiago, Chile.	12 ans
Constanza Sigala	F	-	Algenis SpA Algenis SpA BiotechnologyHealth Technology Algenis SpA conducts research on small molecules derived from microalgae. It produces, formulation and clinical developments bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases. The company also conducted academic clinical research and published their work in several peer-reviewed journals. Algenis was founded in 2002 and is headquartered in Santiago, Chile.	-
Catalina del Río	M	-	Algenis SpA Algenis SpA BiotechnologyHealth Technology Algenis SpA conducts research on small molecules derived from microalgae. It produces, formulation and clinical developments bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases. The company also conducted academic clinical research and published their work in several peer-reviewed journals. Algenis was founded in 2002 and is headquartered in Santiago, Chile.	-